Health
Nanobodies that neutralize SARS-CoV-2 – EurekAlert
Two separate studies have identified nanobodies – which could be produced less expensively than monoclonal antibodies – that bind tightly to the SARS-CoV-2 spike…
Two separate studies have identified nanobodies – which could be produced less expensively than monoclonal antibodies – that bind tightly to the SARS-CoV-2 spike protein and efficiently neutralize SARS-CoV-2 in cells. “The combined stability, potency, and diverse epitope engagement of our … nanobodies … provide a unique potential prophylactic and therapeutic strategy to limit the continued toll of the COVID-19 pandemic,” write authors on one paper (Michael Schoof et al.) In the battle against…
Continue Reading
